DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Seviteronel
Seviteronel
WO 2018/111890 Al 21 June 2018 (21.06.2018) W !P O PCT
Tanibirumab (CUI C3490677) Add to Cart
ESMO E-Learning Metastatic Castrate-Resistant Prostate Cancer
Androgen Receptor Targeted Agents for Castration Resistant Prostate Cancer: a Review of Clinical Effectiveness and Cost- Effectiveness
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
INFOLETTER 5 – COVID-19 04 April 2020
Abiraterone Induces SLCO1B3 Expression in Prostate Cancer Via Microrna‑579‑3P Roberto H
Androgen Receptor Inhibitor Enhances the Antitumor Effect Of
Targeting the Androgen Receptor in Triple-Negative Breast Cancer: Current Perspectives
( 12 ) United States Patent ( 10 ) Patent No .: US 10,786,501 B2 Rajasekhar Et Al
Drug Repurposing for Triple-Negative Breast Cancer
Androgen-AR Axis in Primary and Metastatic Prostate Cancer: Chasing Steroidogenic Enzymes for Therapeutic Intervention
Androgen Receptor Antagonism Drives Cytochrome P450 17A1 Inhibitor Efficacy in Prostate Cancer
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Targeting the Androgen Receptor in Triple-Negative Breast Cancer
Androgen Receptor Antagonism Drives Cytochrome P450 17A1 Inhibitor Efficacy in Prostate Cancer
Bioactive Compound Library Plus (96-Well)
Top View
Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
Chemical Systems Biology Studies of Triple Negative Breast Cancer Cell Lines Recent Publications in This Series
Androgen Receptor Antagonism Drives Efficacy of CYP17 Inhibitors in CRPC
Drug Repurposing Compound Library Plus (96-Well)
Phase 1 Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor
A Population Pharmacokinetic Analysis of the Oral CYP17 Lyase
Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer Shilpa Gupta1, Luke T
Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
Medicinal Use of Testosterone and Related Steroids Revisited
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Post-Menopausal Breast Cancer: from Estrogen to Androgen Receptor